Abiopharma

🔍 Bambino 255 V V UG haftungsbeschrankt (Executive)

Company: Sono Group N.V. (SSM)

Report Date: 2026-09-01

Detailed Transactions and Holdings:

• Sold 3,568 shares of Common Stock at $3.67 per share (Direct)
  Date: 2026-09-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 149,758.00 | transaction_form_type: 4
• Sold 100 shares of Common Stock at $3.6764 per share (Direct)
  Date: 2026-09-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 149,658.00 | transaction_form_type: 4
• Sold 400 shares of Common Stock at $3.6765 per share (Direct)
  Date: 2026-09-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 149,258.00 | transaction_form_type: 4
• Sold 1,200 shares of Common Stock at $3.679 per share (Direct)
  Date: 2026-09-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 148,058.00 | transaction_form_type: 4
• Sold 100 shares of Common Stock at $3.68 per share (Direct)
  Date: 2026-09-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 147,958.00 | transaction_form_type: 4
• Sold 42 shares of Common Stock at $3.69 per share (Direct)
  Date: 2026-09-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 147,916.00 | transaction_form_type: 4
• Sold 6,000 shares of Common Stock at $3.75 per share (Direct)
  Date: 2026-09-01 | Code: S | equity_swap_involved: 0 | shares_owned_after: 141,916.00 | transaction_form_type: 4

Footnotes:

• REMARKS: Following the transactions reported herein, the Reporting Person is no longer the beneficial owner of more than 10% of the Issuer's outstanding Common Stock and therefore is no longer subject to Section 16 solely on account of its beneficial ownership